Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

55 results about "Micromonospora" patented technology

Micromonospora is a genus of bacteria of the family Micromonosporaceae. They are gram-positive, spore-forming, generally aerobic, and form a branched mycelium; they occur as saprotrophic forms in soil and water. Various species are sources of aminoglycoside antibiotics with spellings that end with -micin, such as gentamicin, unlike most other aminoglycoside names that end with -mycin (e.g. neomycin and streptomycin and are produced by Streptomyces spp.).

Engineering bacterium producing gentamicin A and application thereof

The invention belongs to the technical field of medicines, and relates to an engineering bacterium producing gentamicin A and an application thereof. The engineering bacterium is micromonospora purpurea (Micromonospora purpurea) KD1989 with a geneD1 inactivating function, which is registered and collected in China General Microbiological Culture Collection Center (CGMCC) with the collection No. CGMCC No. 8598. The genD1 function in gentamicin biosynthetic gene cluster is inactivated through a gene knockout method, and according to the gene knockout method, shuttle plasmids (such as pGD14 plasmid) are built and knocked out, the pGD14 plasmid is transformed into a gentamicin producing strain, double crossover engineering bacterium micromonospora purpurea GKD1989(delta genK+delta genD1) is screened, the engineering bacterium is fermented, and gentamicin A is determined by detection of metabolites. The engineering bacterium producing gentamicin A produces the single component gentamicin A, which has not been reported in China and foreign countries, so that the industrial production of gentamicin A can be realized; and the production process is simple and easily controlled, the extraction is convenient, the cost is low, and the engineering bacterium meets clean production levels, has stable product quality, and is the first innovative product in the world.
Owner:FUZHOU UNIV +1

Deodorizing compound inoculum for feces of livestock and poultry and preparation method of deodorizing compound inoculum

ActiveCN108913626ACombination newQuick and long-lasting deodorizing effectBacteriaSpecific water treatment objectivesFecesBacterial strain
The invention discloses a deodorizing compound inoculum for feces of livestock and poultry and a preparation method of the deodorizing compound inoculum, and relates to the field of microbe applications. The deodorizing compound inoculum and the preparation method are provided aiming at the problems that the technical cost for chemical deodorization is high, the reaction is complicated, secondarypollution is generated, and the commercial biological deodorant is poor in adaptation and single in function. The deodorizing compound inoculum for feces of livestock and poultry comprises five species of bacteria including bacillus amyloliquefaciens, Alcaligenes faecalis subsp.faecalis, Arthrobacter humicola, Streptomyces levoris and Micromonospora yulongensis. The preparation method of the deodorizing compound inoculum comprises the following steps: fermentation of single bacterial strains, preparation of the compound inoculum, and adding of a fresh culture medium, an activating agent and aprotection agent. The technical scheme has the beneficial effects that the treatment speed and utilization ratio for feces are improved, and the deodorizing effect is rapid and lasting.
Owner:HEFEI INSTITUTES OF PHYSICAL SCIENCE - CHINESE ACAD OF SCI

Bio-fermentation agent for promoting water hyacinth decomposition

The invention discloses a bio-fermentation agent for promoting water hyacinth decomposition. The bio-fermentation agent comprises a compound bacteria agent, nutritional ingredients, soluble carriers and a microelement chelate, wherein the compound bacteria agent comprises two or more of bacillus subtilis, trichoderma viride, phanerochaete chrysosprium, Nocardia and micromonospora. The invention also discloses a preparation method for the bio-fermentation agent. The preparation method comprises the following steps: preparing compound bacteria species, culturing the compound bacteria species to obtain the compound bacteria agent, and finally, mixing the obtained the compound bacteria agent, the nutritional ingredients, the soluble carriers and the microelement chelate in proportion to obtain the required bio-fermentation agent. The fermentation agent can be manufactured to powder and be dissolved in water completely, a use method is simple, and the propagation of pathogenicity microorganism and incubation of ova can be inhibited to prevent the pest and disease damages; after the fermentation agent is mixed with water hyacinth residual bodies, the decomposition of the water hyacinth residual bodies can be obviously promoted and nutrient content is improved. The method is simple and easy to operate, and low in manufacturing cost.
Owner:SHANGHAI CHUANGBO ECOLOGICAL ENG

Gentamicin sulfate prepared through enhanced microbial fermentation, and application method of gentamicin sulfate

The invention claims to protect gentamicin sulfate prepared through enhanced microbial fermentation, and an application method of the gentamicin sulfate. The enhanced microbial engineering bacterium is a Micromonospora purpurea C2 1591 strain which is obtained by screening through a normal-pressure room-temperature plasma mutagenesis technology, and the Micromonospora purpurea C2 1591 strain is registered and collected in the China General Microbiological Culture Collection Center (CGMCC for short, the address is No.3, No.1 Yard, Beichen West Road, Chaoyang District, Beijing) on June 13, 2021, and the collection number is CGMCC No.59450. The screened engineering bacterium for directionally producing gentamicin C2 in high yield can directionally produce the gentamicin C2 in the high yield, the component ratio of gentamicin C2 is increased to 85% or above from the original about 15%, and the highest fermentation titer of an optimized formula is 1184 U/mL through Plackett-Burman design and is increased by 42% than the titer of an original formula. Compared with an original strain, the yield of the gentamicin C2 is increased by three times, in addition, other isomers or impurities are hardly contained, the gentamicin C2 can be directly applied downstream, complex biotransformation and purification is not required, a large amount of cost is saved, and an industrialization requirement is met.
Owner:青岛安惠仕生物制药有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products